Peak6 Investments LLC Denali Therapeutics Inc. Call Options Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$20.96 - $31.05 $161,392 - $239,085
7,700 Added 83.7%
16,900 $492,000
Q2 2024

Aug 13, 2024
SELL
$14.96 - $23.22 $679,184 - $1.05 Million
-45,400 Reduced 83.15%
9,200 $213,000
Q1 2024

May 14, 2024
BUY
$15.83 - $23.35 $864,318 - $1.27 Million
54,600 New
54,600 $1.12 Million
Q1 2021

May 14, 2021
SELL
$53.8 - $81.53 $215,200 - $326,120
-4,000 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$36.89 - $93.56 $147,560 - $374,240
4,000 New
4,000 $335,000

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.29B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email